Skip to main content

Gore RELINE MAX Clinical Study Outcomes

  • Video

Explore durability with principal investigator Peter Soukas, M.D., as he details 3-year outcomes in real-world superficial femoral artery in-stent restenosis lesions treated with the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*.

* As used by Gore, Heparin Bioactive Surface refers to Gore's proprietary CBAS® Heparin Surface.